Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Aug 2026, 02:17
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
MEDANTA reported a standard shift on 52.79%, accelerating from 16.7% in the previous quarter.
The company's revenue growth year-over-year also accelerated to , up from -0.2% in the previous quarter. MEDANTA's marginal operating leverage increased to , accelerating from 11.88% in the previous quarter. The stock's close price, however, decelerated to INR, down from 1417.2 INR in the previous day.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 52.79 % | 16.7 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 16.7 % | 11.88 | ▲ |
| REVENUE_GROWTH_YOY | 26.5 % | -0.2 | ▲ |
| EPS_ACTUAL | 5.423 INR | 4.622 | ▲ |
| EPS_SURPRISE_PERCENT | -0.096 % | -0.133 | ▲ |
| PRICE_CHANGE_PERCENT | -0.635 % | — | - |
| DAILY_VOLUME | 1,20,862 shares | 2,37,879 | ▼ |
| CLOSE_PRICE | 1,408.2 INR | 1,417.2 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.89 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 6 count | 10 | ▼ |
| TARGET_PRICE_PREMIUM | 12.46 % | — | - |